ModivCare, Inc.

As of February 25, 2022, ModivCare, Inc. is considered overvalued and risky due to its negative Price to Book Value, high EV to EBIT ratio of 115.84, and poor stock performance, particularly when compared to its peers.

As of February 25, 2022, ModivCare, Inc. is considered overvalued and risky due to its negative price-to-book value of -0.90, high EV to EBIT ratio of 115.84, and significant underperformance with a return of -86.90% compared to the S&P 500's 10.26%.

As of May 29, 2025, the market trend is mildly bearish, influenced by daily moving averages and mixed monthly indicators, while the weekly MACD shows mild bullishness and the RSI indicates indecision.

ModivCare, Inc. is a micro-cap company in the Transport Services industry, reporting net sales of $651 million and a net loss of $50 million as of March 2025. Key metrics include a market cap of $64.73 million, a negative P/E ratio, and a return on equity of 128.10%.

As of Jun 18, ModivCare, Inc. has a market capitalization of 64.73 million and reported net sales of 2,753.79 million with a net profit of -229.35 million over the latest four quarters. Shareholder's funds are -38.47 million, and total assets amount to 1,654.33 million.